Markets

Insider Trading

Hedge Funds

Retirement

Opinion

1281292 - 11759070 - 1

10 Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds

Page 1 of 4

In this article, we will discuss: 10 Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds.

On June 9, Reuters reported that Philips’ Future Health Index survey concluded that artificial intelligence improved clinical accuracy and increased patient capacity. It also saved healthcare providers’ budgets. A research consultancy, Vitreous World, performed the survey in 10 countries between February and April, surveying 2,011 professionals and 20,085 patients. According to Philips North America CEO Jeff DiLullo, clinicians who use AI might see an additional five patients each week on average, which has an economic impact on the healthcare system. Approximately 30% of surveyed doctors stated AI has resulted in significant budget savings, while 36% said AI boosted the number of patients they treated weekly.

DiLullo told Reuters that AI will progressively transform clinicians’ jobs as healthcare experts continue to make complex medical decisions. Reuters stated that clinicians generally use artificial intelligence for administrative work like data collection and scheduling. The survey also revealed that 77% of clinicians thought AI training was still unavailable, inadequate, or inconsistent. Health insurers, including Centene, have criticized health systems’ use of AI, claiming that it has aggressively or inappropriately triggered increased reimbursement payments. Previous research showed that patients increasingly look out for AI-generated health advice, even though the technology has not proven to be more helpful than other methods for making healthcare decisions.

With that said, here are the 10 Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds.

15 States with the Best Healthcare in the US

Methodology:

We used screeners to identify AI-Powered Healthcare Stocks and limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among analysts and elite hedge funds. We then identified those with the highest number of hedge fund holders, which we assessed using Insider Monkey’s database of hedge funds as of Q1 2026. The stocks are ranked in ascending order of the number of hedge fund holders.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Insider Monkey’s quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 599.2% since May 2014, beating its benchmark by 372 percentage points (see more details here).

10. GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Number of Hedge Fund Holders: 60

GE HealthCare Technologies Inc. (NASDAQ:GEHC) is among the Best Healthcare Stocks.

On June 23, RBC Capital started coverage of GE HealthCare Technologies Inc. (NASDAQ:GEHC) with an “Outperform” rating. The firm had an $80 price target on the shares. The analyst said the company gives an attractive risk-reward profile. The firm has stronger R&D spending and improved commercial execution since its 2023 separation from General Electric. It also has a solid order backlog expected to support faster growth later in 2026.

Separately, on June 9, GE HealthCare Technologies Inc. (NASDAQ:GEHC) said it will showcase its latest cloud-enabled enterprise imaging technologies at the SIIM 2026 Annual Meeting.

The corporation will showcase Genesis Radiology Workspace and InteleShare. Genesis is an approved viewer that lets doctors look at medical scans from anywhere and easily compare old and new images. InteleShare is a secure cloud system used to safely share medical images between different hospitals and clinics.

CEO of Solutions for Enterprise Imaging, GE HealthCare, Scott Miller, said connected cloud and AI-powered technologies can improve efficiency while helping providers streamline imaging workflows.

GE HealthCare Technologies Inc. (NASDAQ:GEHC) works in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It works through Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics divisions.

9. Veeva Systems Inc. (NYSE:VEEV)

Number of Hedge Fund Holders: 62

On June 23, Veeva Systems Inc. (NYSE:VEEV) announced that it acquired Copli and launched Veeva Falcon MLR. It made the agentic medical, legal, and regulatory content-review platform available immediately.

The firm said Veeva Falcon MLR automates reviews of promotional and medical content by checking materials against approved labels and local regulations. The corporation noted that the platform has the potential to eliminate more than 70% of manual MLR work over the next five years.

Copli CEO Jacob Scheel-Bech called the launch “a fundamental shift” in content review. He said the acquisition will help scale the company’s vision for AI-focused MLR while merging its technology with Veeva PromoMats.

Emma Hyland, vice president of Veeva Commercial Content, said the MLR process has long slowed the delivery of information to patients and physicians. She commented that Veeva Falcon MLR can shorten review cycles by automating routine work, allowing reviewers to focus on higher-value responsibilities.

Veeva Systems Inc. (NYSE:VEEV) provides cloud-based software for the life sciences market in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America.

Page 1 of 4

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.